None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adult men and women between the ages of 19 and 64 2) Patients who are diagnosed with persistent positional-perception dizziness below and complain of dizziness with a DHI score of 16 or higher - Persistent nonrotational dizziness for more than 3 months - Hypersensitivity to one's own movement or movement in the surrounding environment persists for more than 3 months - Symptoms worsen in complex visual environments or when precise visual tasks such as reading or computer use are required. 3) A person who has agreed by signing the consent form provided in writing
Exclusion criteria
Exclusion criteria: 1) Those diagnosed with dizziness due to cardiovascular disease (arrhythmia, heart valve disease, anemia, orthostatic hypotension, coronary artery disease, etc.) 2) Those diagnosed with dizziness due to active or uncontrolled disease (e.g., uncontrolled diabetes, high blood pressure, other respiratory and endocrine diseases) 3) Those diagnosed with dizziness due to the medication they are currently taking 4) Those diagnosed with a serious chronic or terminal disease (malignant tumor, chronic renal failure, tuberculosis, etc.) 5) Patients who complain of dizziness associated with cervical movement or cervical posture while accompanied by cervical pain or cervical pain 6) Those diagnosed as abnormal by neurotological examination and brain imaging examination 7) Those who have received other treatment (non-steroidal anti-inflammatory drugs, steroids, etc.) due to dizziness due to vestibular dysfunction within the past month 8) Those who are pregnant, plan to become pregnant during the test period, or are breastfeeding 9) Those suspected of alcohol or drug abuse 10) Those who have participated in another clinical trial within 1 month of the intervention start date 11) People with communication difficulties who find it difficult to follow the tester’s instructions 12) Other people judged by the test director or test manager to be unsuitable for participation in the test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dizziness Handicap Inventory | — |
Secondary
| Measure | Time frame |
|---|---|
| Beck Depression Inventory-II;Beck Anxiety Index;Insomnia Severity Index;EuroQol-5 Dimension-5 Levels & EuroQol Visual Analogue Scale;modified Clinical Global Impression-Improvement Sasang Constitutional Sympotmatology | — |
Countries
Korea, Republic of
Contacts
Kyung Hee University Oriental Medical Center